Cargando…
New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel
Actinic keratosis is a common disease in older, fair-skinned people, and is a consequence of cumulative ultraviolet exposure. It is part of a disease continuum in photodamaged skin that may lead to invasive squamous cell carcinoma. Treatment options frequently used include cryosurgery and topical ph...
Autor principal: | Berman, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430094/ https://www.ncbi.nlm.nih.gov/pubmed/22956883 http://dx.doi.org/10.2147/CCID.S28905 |
Ejemplares similares
-
Efficacy of ingenol mebutate gel for actinic keratosis in patients treated by thiazide diuretics
por: Campione, Elena, et al.
Publicado: (2016) -
Willingness-to-pay to access Ingenol Mebutate Gel for Actinic Keratosis Treatment in the U.S. Setting
por: Willis, Michael, et al.
Publicado: (2014) -
Ingenol mebutate: A novel topical drug for actinic keratosis
por: Aditya, Suruchi, et al.
Publicado: (2013) -
Identification of differentially expressed genes in actinic keratosis samples treated with ingenol mebutate gel
por: Segura, Sonia, et al.
Publicado: (2020) -
Ingenol mebutate in low amounts for the treatment of actinic keratosis in Korean patients
por: Joe, Hyun Jae, et al.
Publicado: (2017)